DEVELOPMENT OF A NEXT-GENERATION ANTIMICROBIAL WOUND DRESSING

Area of Science:

• Wound healing research
• Antimicrobial technologies
• Biomaterials science

Background:

• Delayed wound healing is often caused by infection and the presence of microbial biofilm.
• Biofilm, a protective community of microorganisms, impairs normal wound healing processes and resists conventional treatments.
• Chronic wounds frequently harbor biofilm, contributing to persistent infection and delayed recovery.

Purpose of the Study:

• To develop and evaluate a novel antimicrobial wound dressing with enhanced efficacy against wound biofilm.
• To assess the safety and performance of the new dressing in managing exudate, infection, and promoting healing in challenging wounds.

Main Methods:

• Development of a wound dressing combining a metal chelator, surfactant, pH control, and 1.2% ionic silver in a carboxymethylcellulose matrix.
• In vitro and in vivo testing of the dressing's anti-biofilm action.
• Clinical evaluation through a 42-patient study, 113 clinical evaluations, and post-market surveillance in 112 cases.

Main Results:

• The dressing demonstrated synergistic anti-biofilm action and was proven effective in complex wound models.
• Post-market surveillance showed effective exudate and biofilm management, shifting difficult-to-heal wounds toward healing within 4 weeks.
• Clinical evaluations indicated a reduction in infection signs from 36% to 21% and an average wound size reduction of 62% over 5.4 weeks.

Conclusions:

• The next-generation antimicrobial wound dressing is safe and effective for managing exudate, infection, and biofilm in chronic wounds.
• The dressing facilitates the healing of stubborn wounds, supported by in vitro, in vivo, and clinical evidence.
• Further comparative clinical studies are needed to fully elucidate the clinical and economic benefits of this new dressing technology.